| 1 Zhang ZY.Protein tyrosine phosphatases:structure and function,substrate specificity,and inhibitor development.Annu Rev Pharmacol Toxicol,2002,42:209-234.2 Tonks NK.PTP1 B:from the sidelines to the front lines.FEBS Lett,2003,546:140-148.3 Ramachandran C,Kennedy BP.Protein tyrosine phosphatase1B:a novel target for type 2 diabetes and obesity.Curr TopMed Chem,2003,3:749-757.4 Ahmad F,Azevedo JL,Cortright R,et al.Alteration in skeletalmuscleprotein-tyrosinephosphataseactivityand expressionininsulin-resistanthumanobesityanddiabetes.J Clin Invest,1997,100:449-4585 Ahmad F,Considine RV,Bauer TL,et al.Improved sensitivitytoinsulininobesesubjectsfollowingweightlossis accompanied by reduced protein-tyrosine phosphatases in adiposetissue.Metabolism,1997,46:1140-11456 Su YL(苏彦雷).Research progress on Astragali mongholicus.JStrait Pharm(海峡药学),2009,12:1-4.7 Cheng JF(程杰飞),Wu JF(吴剑飞),Aziguli(阿兹古丽),et al.Study on chemical constituents from the Astragalus altaicus.Chin Tradit Herb Drugs (中草药),1994,25:563-564.8 Wang GY(王光亚).The detection method of functional component in health food(保健食品功效成分检测方法).Beijing:Chinese light industry press,2002:133.9 Yang W,Lu J,Weng J,etal.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-1101.10 Cui L,Ndinteh DT,Na M,et al.Isoprenylated flavonoids from the stem bark of Erythrina abyssinica.JNatProd,2007,70:1039-1042.11 Aihemait W(吾布力哈斯木?艾合买提),Shademhanmd D(迪利夏提?沙德穆罕默德).Clinical observation on 172 cases suffered from diabetes mellitus treated by Uigurian medicine.JMedPharmChinMinor(中国民族医药杂志),2000,6:8-9.12 Wang YQ(王玉芹),Chen N(陈娜),Aisa HA(阿吉艾克拜尔?艾萨),et al.Effect of reducing plasmas glucose of active fractions and chickpea of Uygur medicine.ChinTraditPatent Med(中成药),2007,29:1832-1834 |